SHORTness of Breath In the Emergency Department (SHORTIE)
1 other identifier
interventional
306
1 country
5
Brief Summary
SHORTIE is a two-phase study to determine the impact of the Triage Profiler S.O.B. (Shortness Of Breath) Panel on patient management, outcome, and cost.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Apr 2005
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2005
CompletedFirst Submitted
Initial submission to the registry
September 13, 2005
CompletedFirst Posted
Study publicly available on registry
September 21, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2007
CompletedJuly 27, 2015
July 1, 2015
1.3 years
September 13, 2005
July 23, 2015
Conditions
Outcome Measures
Primary Outcomes (3)
Time to specific treatment for final diagnosis
Length of stay in the emergency department (ED)
ED and total hospital costs
Secondary Outcomes (2)
Outcome at 30 days (Phase I and II) and 90 days (Phase II)
Diagnostic accuracy of the Triage® Profiler S.O.B. panel for acute myocardial infarction (AMI), heart failure (HF) and pulmonary embolism (PE) in patients presenting with S.O.B.
Study Arms (2)
Control-Blinded from Results
NO INTERVENTIONAccess to Results
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Age 18 and older.
- Visit to the ED is due to a primary complaint of shortness of breath alone or shortness of breath with associated chest pain, cough or edema.
You may not qualify if:
- Blood sample cannot be collected before treatment is initiated, specifically CPR or treatment with i.v. diuretics, injectable anticoagulants, thrombolytics
- Patient is unwilling or unable to give consent to participate in the study
- Patient has renal disease requiring dialysis
- Patients with a clear exacerbation of isolated asthma
- Patients with trauma that interferes with normal breathing function
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
University of Massachusetts Medical Center USA
Worcester, Massachusetts, 01655, United States
New York Methodist Hospital
Brooklyn, New York, 11215, United States
Stony Brook University Hospital
Stony Brook, New York, 11794, United States
Duke University Hospital Durham
Durham, North Carolina, 27710, United States
Hospital of the Univ. of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alan Maisel, MD
VA, University of California, San Diego
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 13, 2005
First Posted
September 21, 2005
Study Start
April 1, 2005
Primary Completion
August 1, 2006
Study Completion
August 1, 2007
Last Updated
July 27, 2015
Record last verified: 2015-07